Arcturis Data
Arcturis is transforming real-world clinical care in the UK into high-quality, research-ready data – delivering the depth, recency, and clinical context needed to support confident decision-making across the life sciences.
Arcturis is a UK-based real-world data and evidence company that enables the secure use of rich, patient-level healthcare data to support high-quality research, evidence generation, and decision-making. We work in close partnership with the UK’s National Health Service (NHS) to transform real-world clinical care into fit-for-purpose, research-ready datasets that meet the critical needs of biopharma partners, regulators and health technology assessment bodies.
At the core of Arcturis’ offering is a UK Health Research Authority (HRA)–approved research database – powered by Arcturis’ Real World Data (RWD) network of leading hospitals and health systems in the UK. Built collaboratively with UK clinicians and data experts, the RWD network delivers deeply curated, multi-modal data in near real time, spanning structured and unstructured sources across secondary and specialist care. This enables robust, contemporary insights into patient populations, treatment pathways, and outcomes that are difficult to achieve using traditional UK real-world data sources.
Arcturis’ research database and fit-for-purpose datasets combine comprehensive clinical coverage with methodological rigour, ensuring data are clinically interpretable, analytically robust, and aligned with real-world UK practice – capturing the evolving standard of care and use of the very latest therapeutic interventions. Moreover, our HRA-approval provides delegated ethical approval for real world research conducted on behalf of our partners – enabling rapid study start-up and expedited time to insight.
The Arcturis Offer
- UK data as an accelerant for biopharma innovation: deep, multi-modal UK data provides a unique foundation for generating and testing hypotheses, and a strategic capability for advancing R&D and commercialization objectives
- Near-real time insights: data recency enables exploration of rapidly evolving standard of care and impact of new treatments / combinations with data evidencing contemporary clinical practice and care outcomes
- Expedited evidence generation: our existing research-ready datasets support immediate evidence generation and can inform deeper analysis on fully curated, fit-for-purpose and highly contemporary cohorts
Arcturis’ expert team of consultants, epidemiologists, scientists and medical statisticians support our biopharma partners’ delivery needs end-to-end – from study design, dataset curation to analysis execution. Capabilities span early development through post-approval, aligned to integrated evidence generation objectives. Key use cases include:
- Clinical development / R&D impact, trial design and optimisation
- Deep understanding of disease, patient populations and real-world treatment
- ECAs for single-arm / comparative trials and rare / hard to recruit indications
- MHRA submissions and Health Technology Assessment evaluations
- Post-Authorisation Safety Studies
- Advanced HEOR/HCRU for pre- and post-lauch commercialisation objectives
Through clinically grounded data, near-real-time insight, and rigorous evidence generation, Arcturis enables better, faster decision-making—advancing innovation and impact.
